This is the authors' abstract. We don't add key points for this paper.
Over the past 30 years in the USA, NAFLD is the only liver disease with growing prevalence, synchronous with the increasing rates of obesity and T2DM.
No takes yet. Share an insight, caveat, or question.
Younossi et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: